pet-ct

Documents about pet-ct

• ⁸⁹Zr-Df-IAB22M2C (CD8 PET Tracer) for PET/CT in Patients With Metastatic Solid Tumors#238112ClinicalTrials.gov
• FAPI PET/CT Prospective Interobserver Agreement#850404ClinicalTrials.gov
• A Prospective Study on 18F-DCFPyL PET/CT Imaging in Biochemical Recurrence of Prostate Cancer#874075ClinicalTrials.gov
• Evaluation of PET-CT Scanner Performances to Detect Infra-centimetric Lesions in Patients With Cancer#895368ClinicalTrials.gov
• Role of 18F-FDG PET/CT in Gastric Cancer#842586ClinicalTrials.gov
• Secretory Azoospermia and FDG (Fluoro Deoxyglucose) PET-CT#914607ClinicalTrials.gov
• Different Sonographic Modalities and PET-CT in Pediatric Lymphoma#969893ClinicalTrials.gov
• Pioglitazone Decreases Visceral Fat Metabolism#801273ClinicalTrials.gov
• A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Graft Versus Host Disease Manifestations#898331ClinicalTrials.gov
• Test-Retest Reproducibility of 18F-DCFPyL PET/CT in the Evaluation of Patients With Metastatic Prostate Cancer#908488ClinicalTrials.gov
• 18F-fluoroestradiol (18F-FES) PET/CT Guided First-line Treatment for HR+/HER2- Metastatic Breast Cancer Patients#981629ClinicalTrials.gov
• Innovative procedure for measuring left ventricular ejection fraction from ¹⁸F-FDG first-pass ultra-sensitive digital PET/CT images: evaluation with an anthropomorphic heart phantom#291868HAL (France)
• The Study on the Effectiveness of [68Ga]Ga-HBED-CC-DiAsp PET/CT in Calculating GFR and Predicting Residual Renal Function After Partial Nephrectomy#831034ClinicalTrials.gov
• 68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses#800505ClinicalTrials.gov
• 18F-FDG PET/CT Radiomics Models for Precision Diagnosis and Prognosis in NSCLC#876476ClinicalTrials.gov
• PET/CT to Image Hypoxia in Head and Neck Tumours#910284ClinicalTrials.gov
• Population-based input function (PBIF) applied to dynamic whole-body 68Ga-DOTATOC-PET/CT acquisition#983785HAL (France)
• Dual-tracer PET Radiomics for Prostate Cancer Stratification#845021ClinicalTrials.gov
• [18F]FT8 PET Imaging in Immunoglobulin Light Chain Amyloidosis#909005ClinicalTrials.gov
• Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PET#909882ClinicalTrials.gov
• 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MR#992709ClinicalTrials.gov
• 68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy#249592ClinicalTrials.gov
• 68Ga-Pentikra PET/CT Imaging Study in Healthy Subjects#898957ClinicalTrials.gov
• Early Versus Late FDG-PET/CT in Bladder Cancer#901737ClinicalTrials.gov
• 68Ga-RM2 Compared to 68Ga-PSMA-617 PET/CT for Prostate Cancer Imaging According to Various Metastatic Risks#839420ClinicalTrials.gov
• The Prognostic Value of Interim PET/CT After 2 Cycles of Chemotherapy in Predicting Progression of Non Hodgkins Lymphoma#853582ClinicalTrials.gov
• Programmed Cell Death Ligand 1 PET/CT in Various PD-L1-Related Disease Patients#903232ClinicalTrials.gov
• Preoperative PET or PET/CT for malignant diagnosis of Gastrointestinal stromal tumors: a systematic review and meta-analysis.#174561NCBI PubMed Central
• Preliminary Study on the Diagnostic Value Comparison of 18F-FAPI-04 PET/CT and PET/MR in Gastric Cancer#842920ClinicalTrials.gov
• PSMA-PET Guided Hypofractionated Salvage Prostate Bed Radiotherapy#913617ClinicalTrials.gov
• An Audit of the Patterns of Prostate Carcinoma Metastases in Patients Referred for PSMA PET/CT Imaging at Charlotte Maxeke Johannesburg Academic Hospital#410636WIReDSpace
• Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid Carcinoma#862646ClinicalTrials.gov
• Association Between Arterial Wall Uptake of Fluorodeoxyglucose on PET Imaging and sRAGE#813205ClinicalTrials.gov
• An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer#834355ClinicalTrials.gov
• 68Ga-FAPI PET/CT in Pancreatic Ductal Carcinoma#840440ClinicalTrials.gov
• 68Ga-NOTA-PEG2-RM26 PET/CT, First in Man Study#856937ClinicalTrials.gov
• Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer#906192ClinicalTrials.gov
• Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT#918852ClinicalTrials.gov
• 18F-NaF-PET/MR vs 99mTc-MDP-SPECT/CT to Detect Bone Metastases in Prostate Cancer Patients.#898930ClinicalTrials.gov
• Optimal acquisition time of [⁶⁸Ga]Ga-PentixaFor PET/CT for initial staging of multiple myeloma: an ancillary study to the PentiMyelo protocol#288070HAL (France)
• The Role of 18F-FDG and 68Ga-FAPI PET/CT in the Diagnosis and the Efficacy Evaluation of Advanced Colorectal Cancer (peritoneal Metastasis With/without Other Metastases)#853373ClinicalTrials.gov
• Radiomic Assessment in NSCLC: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers#1008961ClinicalTrials.gov
• Repeatability of semi-quantitative [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT measurements in pancreatobiliary cancers: a test-retest study#205498Europe PMC
• Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active Surveillance#856110ClinicalTrials.gov
• Using Novel Imaging to Rethink Diagnostic and Treatment Strategies for Polymyalgia Rheumatica#828929ClinicalTrials.gov
• Evaluation of the Use of the FUR to Quantify Tumor Glucose Consumption in Oncologic PET#839392ClinicalTrials.gov
• A Prospective Study of ¹⁸F-DFA PET Imaging for the Assessment of Liver Injury#847761ClinicalTrials.gov
• 11C-acetate/18Fluorodeoxyglucose-FDG PET/CT and Cardiac MRI in Pulmonary Hypertension#125999ClinicalTrials.gov
• The PET-CT Predicting Response to Immunochemotherapy in Esophageal Cancer#249601ClinicalTrials.gov
• Hepatic Sugar Metabolism Measured by PET/CT in Patients and Healthy Subjects#261392ClinicalTrials.gov